Cambridge, MA, Reader Meetup Today (10/18) at 4:30p ET

In the Cambridge/Boston area this evening? Join well-connected FierceBiotech readers like yourself for a drink at Bambara Restaurant in Cambridge (map) at 4:30-7:00p ET. No RSVP is required, but feel free to give us a heads up by email or Twitter and we'll look out for you tonight.

We're in town for FierceBiotech's executive breakfast panel Wednesday morning, featuring Peter Mueller (Vertex Pharmaceuticals), Doug Williams (Biogen Idec), Tom Hughes (Zafgen), Omid Farokhzad (Harvard Medical School) and Stephen Knight (Fidelity Biosciences). John Carroll, our esteemed editor-in-chief, will moderate the discussion.

Thanks for being part of the Fierce community. If you're local, hope to see you either this evening or tomorrow.

- Arsalan Arif, Publisher (email | Twitter)

Suggested Articles

It’s been a rocky road for BMS’ immuno-oncology duo in previously untreated lung cancer, but a new addition to the regimen might hold the ticket.

Novartis’ Zolgensma launch has been anything but boring: First a record price, then a data scandal and now a manufacturing-related delay in Europe.

As CEO Paul Hudson focuses Sanofi's R&D program on immuno-oncology and gene therapies, Sanofi is readying a vaccine plant to make viral vectors.